Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias.

Source:http://linkedlifedata.com/resource/pubmed/id/3589697

Download in:

View as

Triples

General Info

PMID
3589697